| DB ID | MyCo_2642 |
| Title | Efficacy of dupilumab and biomarkers for systemic corticosteroid naïve allergic bronchopulmonary mycosis |
| Year | 2020 |
| PMID | 32917523 |
| Fungal Diseases involved | Allergic bronchopulmonary aspergillosis |
| Associated Medical Condition | None |
| Genus | Penicillium |
| Species | spp. |
| Organism | Penicillium spp. |
| Ethical Statement | None |
| Site of Infection | None |
| Opportunistic invasive | None |
| Sample type | Body fluid |
| Sample source | Serum |
| Host Group | Human |
| Host Common name | Human |
| Host Scientific name | Homo sapiens |
| Biomarker Name | CCL2 |
| Biomarker Full Name | CCL2 |
| Biomarker Type | Diagnostic |
| Biomolecule | Protein |
| Geographical Location | Japan |
| Cohort | A 72-year-old Japanese woman who had cataract and treatment history of non-tuberculosis mycobacterium (NTM) had been treated with inhaled corticosteroid, long acting b2 adrenergic agonist, long acting muscarinic antagonist and leukotriene receptor agonist for asthma diagnosed 5 years ago and experienced asthma exacerbations for twice in previous year. She had no history of sinusitis, smoking, dust exposure, or treatment with anti-fungal agents was included in the study. |
| Cohort No. | 1 |
| Age Group | 72 |
| P Value | None |
| Sensitivity | None |
| Specificity | None |
| Positive Predictive Value | None |
| MIC | None |
| Fold Change | None |
| Pathway | None |
| Disease Introduction Mechanism | None |
| Technique | ELISA |
| Analysis Method | ELISA Based |
| ELISA kits | multiplex ELISA Kit (Eve Technologies, Calgary, Alberta, Canada) and (for periostin, Shino-test, Tokyo, Japan). |
| Assay Data | None |
| Validation Techniques used | multiplex ELISA assay |
| Up Regulation Down Regulation | Increase |
| Sequence Data | None |
| External Link | None |
